Managed Care

Chronic disease cited as reason for increase in drug expenditures











Retail prescription drug sales, in terms of dollars, rose 17.3 percent in 2001, though increases varied widely from state to state. An audit by Verispan Scott-Levin shows that increases in drug expenditures ranged from 12 percent in Maine to 25 percent in Alaska. Verispan Scott-Levin collects information from over 140 million prescription claims monthly, covering 71 percent of retail dispensing activity nationwide. Verispan is a new joint venture of Quintiles Transnational Corp. (which included Scott-Levin) and McKesson Corp.

Increase in expenditures, by state

SOURCE: VERISPAN SCOTT-LEVIN, SOURCE PRESCRIPTION AUDIT, 2001

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.